{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-085144","form_type":"8-K","ticker":"SPRB","cik":"0001683553","company_name":"SPRUCE BIOSCIENCES, INC.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.331712+00:00","generated_at":"2026-05-19T10:47:58.166841+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Spruce Biosciences wins Nasdaq appeal; must regain bid price compliance by Aug 5","bullets":["Received Nasdaq delisting notice April 22, 2025; stock moved to OTC Pink on April 29, 2025.","On June 9, 2025, Nasdaq Hearings Panel accepted appeal; stock may resume on Nasdaq Capital Market if compliance met by August 5, 2025.","Panel retains jurisdiction until October 20, 2025; any future non-compliance must be reported to the panel.","Company seeks stockholder approval for reverse stock split (1:50 to 1:100) at July 22, 2025 annual meeting to cure bid price deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-085144","json":"https://secwatch.observer/filing/0000950170-25-085144.json","markdown":"https://secwatch.observer/filing/0000950170-25-085144.md","text":"https://secwatch.observer/filing/0000950170-25-085144.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1683553/000095017025085144/0000950170-25-085144-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1683553/000095017025085144/sprb-20250609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:47:58.166841+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}